Total planned funding: $120,701,220
Allocations
Countries/Regions
Ukraine | $120,701,220 |
Organizational Types
Unknown | $34,043,032 |
Private Contractor | $28,228,578 |
NGO | $20,323,328 |
Own Agency | $13,653,562 |
Multi-lateral Agency | $10,288,586 |
Other USG Agency | $4,589,094 |
Implementing Agency | $4,125,040 |
University | $3,850,000 |
Host Country Government Agency | $1,600,000 |
Program Areas
Governance and Systems | $50,725,230 |
Treatment | $22,102,678 |
Prevention | $17,054,445 |
Testing | $10,422,381 |
Management and Operations | $10,073,140 |
Care | $9,910,646 |
Budget Codes
OHSS: Health Systems Strengthening | $27,638,365 |
HVSI: Strategic Information | $13,291,601 |
HTXD: Treatment: ARV Drugs | $11,405,290 |
HTXS: Treatment: Adult Treatment | $10,697,388 |
HVCT: Testing: HIV Testing and Counseling | $10,422,381 |
HVMS: Management and Operations | $10,073,140 |
HLAB: Laboratory Infrastructure | $9,795,264 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $7,847,216 |
HVOP: Sexual Prevention: Other Sexual Prevention | $5,988,440 |
HVTB: Care: TB/HIV | $5,850,861 |
HMBL: Biomedical Prevention: Blood Safety | $2,742,932 |
HKID: Care: Orphans and Vulnerable Children | $2,473,444 |
HBHC: Care: Adult Care and Support | $1,586,341 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $182,500 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$34,747,748
Countries/Regions
Chemonics International:
$16,839,470
Countries/Regions
USG Aggregated Agencies:
$12,304,562
Countries/Regions
Deloitte Consulting Limited:
$10,239,108
Countries/Regions